Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline dose-escalation study in resistant malignant ascites
IRCT20140113016200N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of minocycline in malignant ascites, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Ascitic fluid volume, VEGF and 1 more. Started Mar 2019; status: completed.
02
Drugs
minocycline
03
Conditions
malignant ascites
Beyond the preview
Go deeper on IRCT20140113016200N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140113016200N2.